Inhibitory effects of bile acids and synthetic farnesoid X receptor agonists on rotavirus replication

Journal of Virology

Volumn 85, Issue 23, 2011, Pages 12570-12577

  Kim, Yunjeong ^a   Changk, Kyeong Ok ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [2 [2 CHLORO 4 [3 (2,6 DICHLOROPHENYL) 5 ISOPROPYL 4 ISOXAZOLYLMETHOXY]PHENYL]VINYL]BENZOIC ACID; 4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHALENYL)1 PROPENYL]BENZOIC ACID; BILE ACID; CHENODEOXYCHOLIC ACID; CHOLIC ACID; DEOXYCHOLIC ACID; FARNESOID X RECEPTOR; FARNESOID X RECEPTOR STIMULATING AGENT; FEXARAMINE; GLYCOCHENODEOXYCHOLIC ACID; GLYCOCHOLIC ACID; HORMONE RECEPTOR STIMULATING AGENT; NITAZOXANIDE; OBETICHOLIC ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; ROTAVIRUS; ROTAVIRUS INFECTION; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS SHEDDING;

ANIMALS; BLOTTING, WESTERN; CACO-2 CELLS; CARCINOMA, HEPATOCELLULAR; CHENODEOXYCHOLIC ACID; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; ISOXAZOLES; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS; ROTAVIRUS; ROTAVIRUS INFECTIONS; TRIGLYCERIDES; TUMOR CELLS, CULTURED; VIRUS REPLICATION;

MUS; ROTAVIRUS; ROTAVIRUS A;

EID: 81255184288     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05839-11     Document Type: Article

References (45)

1. Akashi, Y., H. Miyazaki, and F. Nakayama. 1983. Correlation of bile acid composition between liver tissue and bile. Clin. Chim. Acta 133:125-132.
2. Anisfeld, A. M., et al. 2003. Syndecan-1 expression is regulated in an isoformspecific manner by the farnesoid-X receptor. J. Biol. Chem. 278:20420-20428.
3. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
4. Chang, K. O. 2009. Role of cholesterol pathways in norovirus replication. J. Virol. 83:8587-8595.
5. Chang, K. O., and D. W. George. 2007. Bile acids promote the expression of hepatitis C virus in replicon-harboring cells. J. Virol. 81:9633-9640.
6. Chang, K. O., et al. 2004. Bile acids are essential for porcine enteric calici- virus replication in association with down-regulation of signal transducer and activator of transcription 1. Proc. Natl. Acad. Sci. U. S. A. 101:8733-8738.
7. Cheung, W., et al. 2010. Rotaviruses associate with cellular lipid droplet components to replicate in viroplasms, and compounds disrupting or blocking lipid droplets inhibit viroplasm formation and viral replication. J. Virol. 84:6782-6798.
8. Choi, A. H., M. Basu, M. M. McNeal, J. D. Clements, and R. L. Ward. 1999. Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein. J. Virol. 73:7574-7581.
9. Craddock, A. L., et al. 1998. Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am. J. Physiol. 274:G157-G169.
10. Cuadras, M. A., and H. B. Greenberg. 2003. Rotavirus infectious particles use lipid rafts during replication for transport to the cell surface in vitro and in vivo. Virology 313:308-321.
11. Danielsson, H., and J. Sjövall (ed.). 1985. Sterols and bile acids. Elsevier Science Publishers B.V., Amsterdam, Netherlands.
12. De Fabiani, E., et al. 2004. Bile acid signaling to the nucleus: finding new connections in the transcriptional regulation of metabolic pathways. Biochimie 86:771-778.
13. Duran-Sandoval, D., et al. 2004. Glucose regulates the expression of the farnesoid X receptor in liver. Diabetes 53:890-898.
14. Edwards, P. A., H. R. Kast, and A. M. Anisfeld. 2002. BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis. J. Lipid Res. 43:2-12.
15. Estes, M. K., D. Y. Graham, E. M. Smith, and C. P. Gerba. 1979. Rotavirus stability and inactivation. J. Gen. Virol. 43:403-409.
16. Estes, M. K., and A. Z. Kapikian. 2007. Rotaviruses, p. 1917-1974. In D. M. Knipe et al. (ed.), Fields virology, 5th ed., vol. 2. Lippincott Williams & Wilkins, Philadelphia, PA.
17. Farthing, M. J. 2001. Treatment of gastrointestinal viruses. Novartis Found. Symp. 238:289-300; discussion, 300-305.
18. Frolov, A., et al. 2000. High density lipoprotein-mediated cholesterol uptake and targeting to lipid droplets in intact L-cell fibroblasts. A single- and multiphoton fluorescence approach. J. Biol. Chem. 275:12769-12780.
19. Gangl, A. 1975. The lipid metabolism of the small intestine and its correla- tion to the lipid and lipoprotein metabolism of the total organism. Acta Med. Austriaca Suppl. 2:1-49.
20. Geyer, J., T. Wilke, and E. Petzinger. 2006. The solute carrier family SLC10: more than a family of bile acid transporters regarding function and phylogenetic relationships. Naunyn Schmiedebergs Arch. Pharmacol. 372:413-431.
21. Greenspan, P., E. P. Mayer, and S. D. Fowler. 1985. Nile red: a selective fluorescent stain for intracellular lipid droplets. J. Cell Biol. 100:965-973.
22. Heubi, J. E., and W. F. Balistreri. 1980. Bile salt metabolism in infants and children after protracted infantile diarrhea. Pediatr. Res. 14:943-946.
23. Heubi, J. E., W. F. Balistreri, and F. J. Suchy. 1982. Bile salt metabolism in the first year of life. J. Lab. Clin. Med. 100:127-136.
24. Karpen, S. J. 1999. Bile acids go nuclear! Hepatology 30:1107-1109.
25. Kelly, D. A. (ed.). 2008. Diseases of the liver and biliary system in children. Blackwell, Oxford, United Kingdom.
26. Kordasti, S., et al. 2006. Rotavirus infection is not associated with small intestinal fluid secretion in the adult mouse. J. Virol. 80:11355-11361.
27. Makishima, M., et al. 1999. Identification of a nuclear receptor for bile acids. Science 284:1362-1365.
28. Maloney, P. R., et al. 2000. Identification of a chemical tool for the orphan nuclear receptor FXR. J. Med. Chem. 43:2971-2974.
29. McNeal, M. M., et al. 2006. Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA. Virology 346:338-347.
30. Miyanari, Y., et al. 2007. The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell Biol. 9:1089-1097.
31. Mohan, K. V., J. Muller, and C. D. Atreya. 2008. Defective rotavirus particle assembly in lovastatin-treated MA104 cells. Arch. Virol. 153:2283-2290.
32. Ogawa, K., et al. 2009. Hepatitis C virus utilizes lipid droplet for production of infectious virus. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 85:217-228.
33. O'Neal, C. M., G. R. Harriman, and M. E. Conner. 2000. Protection of the villus epithelial cells of the small intestine from rotavirus infection does not require immunoglobulin A. J. Virol. 74:4102-4109.
34. Parks, D. J., et al. 1999. Bile acids: natural ligands for an orphan nuclear receptor. Science 284:1365-1368.
35. Patton, J. B., R. R. Rowland, D. Yoo, and K. O. Chang. 2009. Modulation of CD163 receptor expression and replication of porcine reproductive and respiratory syndrome virus in porcine macrophages. Virus Res. 140:161-171.
36. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
37. Rossignol, J. F., M. Abu-Zekry, A. Hussein, and M. G. Santoro. 2006. Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial. Lancet 368:124-129.
38. Samsa, M. M., et al. 2009. Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog. 5:e1000632.
39. Sirvent, A., et al. 2004. The farnesoid X receptor induces very low density lipoprotein receptor gene expression. FEBS Lett. 566:173-177.
40. Trauner, M. 2003. When bile ducts say NO: the good, the bad, and the ugly. Gastroenterology 124:847-851.
41. Trauner, M., and J. L. Boyer. 2003. Bile salt transporters: molecular characterization, function, and regulation. Physiol. Rev. 83:633-671.
42. Ward, R. L., M. M. McNeal, and J. F. Sheridan. 1990. Development of an adult mouse model for studies on protection against rotavirus. J. Virol. 64:5070-5075.
43. Watanabe, M., et al. 2004. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J. Clin. Invest. 113:1408-1418.
44. Yamagata, K., et al. 2004. Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1. J. Biol. Chem. 279:23158-23165.
45. Yu, J., et al. 2002. Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity. J. Biol. Chem. 277: 31441-31447.